Skip to content

Assessment of the Efficacy of Tracheal Oxygen Administration During Bronchoscopy - a Phase II Trial

Assessment of the Efficacy of Tracheal Oxygen Administration During Bronchoscopy - a Phase II Trial.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01786642
Enrollment
40
Registered
2013-02-08
Start date
2013-02-28
Completion date
2014-04-30
Last updated
2013-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxaemia

Brief summary

The aim of the present study is to measure the time to correction of O2 saturation when in case of desaturation below 90%, O2 administration is switched from the nasal to the tracheal route at a similar flow rate.

Detailed description

The development of a flexible bronchoscope with a channel dedicated to O2 administration might allow optimization of the oxygen supplementation during bronchoscopy, which reduces the risk of per- and peri-procedural hypoxemia. The investigators will conduct a pilot study corroborating the hypothesis that tracheal supplementation of oxygen during flexible bronchoscopy is advantageous in comparison to nasal cannula supplementation. The concept of our trial consists of a mono-centric observational study performed in the endoscopy suite of the Respiratory Division, University Hospitals Leuven. All patients will be given informed consent before inclusion. The aim of the present study is to measure the time to correction of O2 saturation when in case of desaturation below 90%, O2 administration is switched from the nasal to the tracheal route at a similar flow rate.

Interventions

None listed

Sponsors

KU Leuven
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients referred for flexible bronchoscopy

Exclusion criteria

* broncho-alveolar lavage * endobronchial plugging

Design outcomes

Primary

MeasureTime frame
Time to correction of SpO2procedure

Countries

Belgium

Contacts

Primary ContactJonas Yserbyt, MD
jonas.yserbyt@uzleuven.be+3216346801

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026